Brain injury is a serious complication of intrauterine growth restriction (IUGR), but the exact mechanism remains unclear. While glucocorticoids (GCs) play an important role in intrauterine growth and development, GCs also have a damaging effect on microvascular endothelial cells. Moreover, intrauterine adverse environments lead to fetal growth restriction and the hypothalamus-pituitary-adrenal (HPA) axis resetting. In addition, chronic stress can cause a decrease in the number and volume of astrocytes in the hippocampus and glial cells play an important role in neuronal differentiation. Therefore, it is speculated that the effect of GCs on cerebral neurovascular units under chronic intrauterine stimulation is an important mechanism leading to brain injury in infants with growth restrictions.
Introduction
Intrauterine growth restriction (IUGR), a high-risk factor of neurodevelopmental abnormalities, refers to the fetus affected by various unfavorable factors and failure to achieve the potential growth rate, resulting in neonatal death. For example, the birth weight is less than two standard deviations of the average weight or the 10th percentile of the normal weight of the same gestational age. Some outcomes of IUGR include, cognitive and memory dysfunction and permanent mental and neurological disorders [1] , [2] . Nerve injury is a serious complication of IUGR, but the exact mechanism remains unclear. With more research studying the central nervous system in recent years, the concept of the neurovascular unit (NVU) has gradually been accepted by the medical community, referring to a concept consisting of neurons, astrocytes, brain microvascular endothelial cells, microglia and the extracellular matrix that maintains the integrity of brain tissue [3] , [4] . This term reflects the interaction and dynamics of various cells in the brain tissue. Therefore, further research on the mechanism of NVU injury may be the key to reduce IUGR nervous system injury.
Effects of glucocorticoids (GCs) on infants with IUGR
Fetal growth and development are complex processes regulated by multiple factors. Pregnancy stress such as pregnancy-induced hypertension, preeclampsia, malnutrition, chronic anemia and other adverse environmental stimuli lead to imbalances in the nutritional needs and supply of the fetus, resulting in IUGR, metabolism and endocrine adaptive changes [5] . These changes lead to abnormalities in the hypothalamic-pituitary-adrenal axis (HPA) [6] , [7] and subsequently in metabolism and the endocrine, behavioral and cardiovascular systems. We screened GC-related genes in IUGR rat brain tissues with the Affymetrix Rat Gene 2.0ST chip and found that the expression of glucocorticoid receptor (GR or nuclear receptor subfamily 3, group C, member 1, GR, Nr3c1) and the receptor pre-regulatory enzyme 11β-hydroxysteroid dehydrogenase 2 (11β-HSD2) were significantly higher than those of normal rats, suggesting that GCs are abnormal in IUGR rats [8] , [9] . However, the mechanism of GC regulation and its role in IUGR brain injury are still unclear.
Excess cortisol induced by maternal chronic stress during pregnancy can damage fetal brain, down-regulate the expression of GRs, impair negative feedback regulation on the HPA axis, as well as neurotransmitter activity, leading to neurodevelopmental abnormalities in offspring [10] , [11] . Studies have shown that multiple adverse intrauterine environments can reduce the expression of placental 11β-HSD2 and open the placental barrier, exposing the fetus to maternal GC. The hippocampus is an important part of the functional adjustment center in the HPA axis. Changes in the expression of 11β-hydroxysteroid dehydrogenase 11β-HSD1 and 11β-HSD2 in the fetal hippocampus lead to local metabolic activation and can indirectly affect the normal development of the fetal HPA axis by affecting hippocampal function [12] , [13] , [14] . The appropriate amount of GCs in late pregnancy can promote the development and maturation of fetal organs, especially the lungs. Excessive GCs during pregnancy not only causes intrauterine growth retardation but also codes for the adult diseases, such as high blood pressure, diabetes, cardiovascular and cerebrovascular diseases and other metabolic diseases [11] , [15] . Although GCs are fat-soluble hormones, there is still a GC concentration difference of approximately 10:1 between the maternal and fetal side of pregnancy. This concentration difference is mainly attributed to the placental GC barrier. It is composed of the syncytiotrophoblast cells in the placenta and its substance is 11β-HSD2. Its role is to dehydrogenate the bioactive corticosteroid cortisol to 11-dehydrocorticosterone without biological activity. Therefore, a sufficient amount of 11β-HSD2 during pregnancy can inactivate maternal-derived excess cortisol, avoiding exposure of the fetus to an excessive amount of GC environment and ensuring the normal growth and development of the fetus [16] . In addition, the study showed that excessive GCs during pregnancy can inhibit the proliferation of certain fetal cells but also promote the differentiation of these cells (such as adipocyte precursors, osteoblasts, etc.) which will make the organs priority to development [17] . Therefore, if the fetal organ does not get enough growth before it matures, growth restriction will occur. Intrauterine growth retardation in fetal rats may be caused by the injection of the synthetic GC dexamethasone or the inhibitor of ketogenic 11β-HSD2 during gestation, which may cause neurological diseases, cardiovascular diseases, and diabetes in adult rats [18] .
Effects of GC/GR/glucocorticoid receptor interacting protein 1 (GRIP1) on cerebral neurovascular units
We have observed the impact of folic acid intervention on IUGR brain development through brain development molecular markers, including DNA methyltransferase 1 (DNMT1), growth-associated protein (GAP43) and vascular endothelial growth factor receptor (VEGFR1). The results showed that the expression of DNMT1 and GAP43 in the IUGR group was significantly up-regulated both at the transcription and the protein level, but there was no difference in the expression of VEGFR1 between the groups. This suggests that the brain injury of IUGR may be mainly manifested in delayed myelination and synaptic maturation [19] . However, the specific mechanism is unknown.
Basal GCs have a positive effect on normal behavior, cognition and mood, which is mainly achieved through the regulation of synaptic plasticity and neuroprotection [20] , [21] , [22] . The development of the nervous system is closely related to the formation of synapses. However, excessive exposure to GCs during pregnancy interferes with the normal development of the nervous system in the fetus [23] . Studies have shown that whether or not the offspring is exposed to a high GC environment due to stress during maternal gestation, or because treatment requires the injection of GCs during maternal gestation, this situation will lead to an increased risk of offspring behavioral and emotional disorders [24] , [25] , [26] . Studies have confirmed that individuals with early chronic stress will secrete more corticotropin releasing hormone (CRH) in the hippocampus, resulting in high levels of CRH causing abnormal processes such as hippocampal spines branching and synapse formation leading to hippocampal brain function defects [27] . When stress affects the expression of GR in the hippocampus, the negative feedback regulation of the HPA axis will be affected. Many experimental studies have also confirmed that the presence of long-term increased GC will reduce the expression of GR, weaken the inhibition of the HPA axis and make the HPA axis stress response persistently, resulting in alterations of the hippocampus structure and function [28] . The GC exerts its physiological and pathological functions by activating GR and GR effects GCs. The activated GR dimer transported into the nucleus can exert transcriptional regulation through various pathways. At present, the key factors include the number of GRs and the process of nuclear translocation into the nucleus. It is worth noting that the GR of the central nervous system is not only expressed in neurons but also widely distributed in astrocytes, microglia and other cells. Moreover, GCs may cause a decrease in the number of astrocytes mediated by a decrease in GR expression, whereas the role of astrocytes in IUGR brain development remains unclear [29] . Increasing evidence shows that glial cells not only play roles in supporting nutrition and metabolism, but also regulates the development and maturation of synapses. Some studies reported, after activating glial cells, glial cell line derived neurotrophic factor (GDNF) can participate in the information transmission process between neurons and glial cells. Furthermore, glial cells can regulate the structure and function of synapses [30] , the synapse formation, the stable maintenance of synaptic connections, and the process of synapse elimination through some adhesion molecules and cytokines [31] . In addition, glial cells play an important role in neuronal differentiation and loop formation, and most of these effects are mediated by GDNF [32] . The growth of astrocytes is closely related to the function of neurons. Chronic stress stimuli can also cause a decrease in the number and volume of astrocytes in the hippocampus [33] .
GRIP1, also known as steroid nuclear receptor coactivator 2 (SRC-2), or transcriptional intermediary factor 2 (TIF2), is a member of the steroid receptor coactivator (SRC) family. This protein can activate gene transcription, regulate cell growth, proliferation, differentiation and inflammation. Moreover, GRIP1 is both a co-activator and a co-inhibitor and is stimulated by hormones or signaling ligands to interact with nuclear receptors and is recruited by transcription factors to form a complete transcriptional complex that binds to chromatin [34] . In this process, a group of chromatin remodeling enzymes with methyl-transferase activity plays a key role. As GRIP1 binds to nuclear receptors, it recruits chromatin remodeling enzymes to methylate GRIP1, allowing transcription complexes to bind to gene promoters, promoting chromosome allosteric and transcription initiation complex formation [35] . During the development and plasticization period, the adverse environment changes DNA methylation and histone modification, even expression of some important genes, and then causes adverse effects such as cell and organ dysfunction, growth restriction and ultimately causes disease. This process is known as development programming. The change of epigenetics in IUGR has provided a new direction for the study of its pathogenesis. Therefore, the use of reversible changes of epigenetics can provide a new method to treat diseases [36] , [37] .
GCs have a damaging effect on microvascular endothelial cells, leading to endothelial cell damage, and even apoptosis and death [38] . GCs promote the expression of vasoactive and procoagulant factors and related receptors secreted by endothelial cells, while reducing the expression of vasodilators and their receptors and angiogenesis-related genes. Studies have found that GCs can inhibit the expression of vascular endothelial growth factor (VEGF), transforming growth factor p (TGF-p) and prevent the degradation of the vascular basement membrane. GCs can also inhibit the expression of metalloproteinases and prevent the migration of endothelial cells and the formation of blood vessels [39] .
Excessive GC exposure during pregnancy is closely related to fetal growth restriction. The use of GCs during pregnancy can reduce the brain weight of the sheep and delay the maturation of neurons, the formation of myelin and the maturation of the cerebral glial cerebrovascular. With this, the mechanism of nerve injury in IUGR is still unclear. Therefore, to explore the effect of GCs on IUGR brain development from the perspective of cerebrovascular nerve units may be a novel way to reduce IUGR brain damage and reduce morbidity.
